Description
Mechanism of Action:
✔ Metformin (500 mg ER): Lowers hepatic glucose production and enhances glucose uptake.
✔ Glimepiride (1 mg, 2 mg): Increases pancreatic insulin secretion for improved glycemic control.
Indications:
✔ Type 2 Diabetes Mellitus
✔ Patients requiring dual therapy to achieve glycemic targets
Key Benefits:
✅ Effective combination for blood sugar control
✅ Reduces insulin resistance
✅ Extended-release formulation for prolonged action
Dosage & Administration:
- Recommended Dosage: One tablet daily or as prescribed.
- Route of Administration: Oral
- Food Intake: Take before meals to maximize effectiveness.
Precautions & Warnings:
- Not suitable for Type 1 diabetes or diabetic ketoacidosis.
- Monitor blood sugar regularly to avoid hypoglycemia.
- Use cautiously in patients with kidney or liver conditions.
Possible Side Effects:
- Hypoglycemia (low blood sugar)
- Gastrointestinal discomfort (nausea, bloating)
- Weakness or dizziness
Storage & Packaging:
- Store below 30°C in a cool, dry place.
- Available in blister packs and bulk packaging.
Manufacturing & Regulatory Compliance:
Manufactured by Aetos Life Care in WHO-GMP certified facilities, ensuring compliance with EU-GMP standards.
Global Export & Supply:
Aetos Life Care exports Metformin (ER) + Glimepiride Tablets 500 mg + 1 mg, 2 mg to Latin America, Africa, Asia, Europe, and CIS countries, providing high-quality and affordable diabetes management worldwide.
